Financials
Financial year 2025
Asclepia MedChem Solutions from Destelbergen, company number BE0809491031, closed financial year 2025 with a result of € 130,178 after tax. For that financial year Asclepia MedChem Solutions recorded a gross margin of € 206,845 and equity of € 284,957. Compared with financial year 2024, the result moved from € 105,361 to € 130,178. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.
€ 284,957
▲ 77% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 130,178
▲ 24% vs 2024
Profit after tax over the fiscal year.
€ 278,619
▲ 86% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 6,299 paid out
5 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 11,653
▼ 55% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 16,778
▲ € 13,175 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 46,943
▲ 38% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 7,596 | € 45,856 | € 165,215 | € 206,845 | ▲ 25% |
| Profit after taxes | € 367 | € 26,361 | € 105,361 | € 130,178 | ▲ 24% |
| Equity | € 59,528 | € 55,717 | € 161,077 | € 284,957 | ▲ 77% |
| Total debts | € 12,960 | € 34,305 | € 44,264 | € 75,785 | ▲ 71% |
| Cash | € 37,200 | € 48,963 | € 149,695 | € 278,619 | ▲ 86% |
| Retained profit | € 40,928 | € 54,717 | € 160,077 | € 283,957 | ▲ 77% |
| Dividend | € 47,714 | € 12,572 | € 0 | € 6,299 | |
| Balance sheet total | € 72,488 | € 90,022 | € 205,341 | € 360,741 | ▲ 76% |
Key figures of Asclepia MedChem Solutions, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Asclepia MedChem Solutions?
What happened at Asclepia MedChem Solutions in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 130,178 (▲ 24% vs 2024). Source: NBB ↗
- Start of the company according to the CBE. KBO
- New establishment in Destelbergen. KBO
- Petra Blom became a director. NBB
In short
From € 367 profit in 2022 to € 130,178 profit in 2025.
Paid € 123,092 in corporate taxes since 2022.
Best year ever: 2025, with € 130,178 profit.
Paid out € 66,586 in dividends to the owners in total.
A new publication or filing at Asclepia MedChem Solutions? We notify you, reason included.
Follow Asclepia MedChem SolutionsDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Asclepia MedChem Solutions is Petra Blom.
Directors
According to the 2025 annual accounts
Petra Blom
Director
since 2009
Establishments
Establishment units
Physical locations of this company
Damvalleistraat 49
9070 Destelbergen
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0809.491.031
- VAT number
- BE 0809.491.031
- Registered office
- Damvalleistraat 49, 9070 Destelbergen
- Names & denominations
- Asclepia MedChem Solutions
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 30 January 2009
- Peppol
- Active · Active since 5 Oct 2025
- Activities · NACE
Vervaardiging van farmaceutische grondstoffen
Fokken en houden van andere dieren
Markt- en opinieonderzoek
Fokken van andere dieren